California State Teachers Retirement System (CalSTRS)’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$737K Buy
37,839
+8,543
+29% +$155K ﹤0.01% 2059
2026
Q1
$546K Hold
29,296
﹤0.01% 2030
2025
Q4
$386K Buy
29,296
+10,324
+54% +$122K ﹤0.01% 2171
2025
Q3
$136K Hold
18,972
﹤0.01% 2266
2025
Q2
$895K Hold
18,972
﹤0.01% 1795
2025
Q1
$741K Hold
18,972
﹤0.01% 1862
2024
Q4
$1.03M Sell
18,972
-241
-1% -$12.3K ﹤0.01% 1757
2024
Q3
$969K Buy
19,213
+4,969
+35% +$233K ﹤0.01% 1796
2024
Q2
$626K Sell
14,244
-2,122
-13% -$89.9K ﹤0.01% 1988
2024
Q1
$822K Buy
16,366
+429
+3% +$23.3K ﹤0.01% 1905
2023
Q4
$962K Sell
15,937
-111
-0.7% -$5.72K ﹤0.01% 1852
2023
Q3
$915K Buy
+16,048
New +$886K ﹤0.01% 1847

Other funds holding MLTX

California State Teachers Retirement System (CalSTRS)'s MLTX Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) increased its MoonLake Immunotherapeutics (MLTX) stake by 29% in Q2 2026, buying an estimated $155K and bringing the position to 37,839 shares worth $737K. The position accounts for ﹤0.01% of the portfolio, ranked #2059.

California State Teachers Retirement System (CalSTRS) first reported a position in MLTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.03M in Q4 2024. 173 funds tracked by Wall St. Rank hold MLTX as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 37,839 shares of MoonLake Immunotherapeutics worth $737K as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) bought 8,543 MoonLake Immunotherapeutics shares in Q2 2026, an estimated $155K.
  • MoonLake Immunotherapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2059 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in MoonLake Immunotherapeutics in Q3 2023 and has held it in 12 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s MoonLake Immunotherapeutics position peaked at $1.03M in Q4 2024.
  • 173 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.